A. Fꢂrstner et al.
Compound 16a (X=Cl): pale yellow solid (278 mg, 62%). In solution,
this product exists as an equilibrium mixture of the cationic form, the
neutral form, and PPh3 (neutral/cationic/PPh3 0.37:1:0.34). 1H NMR
(400 MHz, CD2Cl2): d=7.80–7.68 (m, 15H), 7.59–7.47 (m, 24H), 7.45–
7.47 (m, 6H), 7.32–7.27 (m, 15H), 3.51 (s, 6H), 3.33 (s, 6H), 2.96–2.91
(m, 2H), 2.49 (ddd, J=12.7, 7.8, 4.8 Hz, 2H), 2.31 (t, J=6.0 Hz, 4H),
1.68–1.65 (m, 1H), 1.31–1.24 (m, 1H), 0.93 (quint., J=5.9 Hz, 2H);
13C NMR (100 MHz, CD2Cl2): d=187.4 (C), 186.0 (C), 137.2 (C, PPh3),
134.5 (d, J(C,P)=11.4 Hz, CH), 134.4 (t, J(C,P)=6.4 Hz, CH), 133.7 (d,
J(C,P)=19.6 Hz, CH, PPh3), 131.9 (CH), 131.3 (d, J(C,P)=2.6 Hz, CH),
130.6 (d, J(C,P)=52.4 Hz, C), 129.4 (d, J(C,P)=25.1 Hz, C), 129.1 (t,
J(C,P)=5.2 Hz, CH), 128.8 (CH, PPh3), 128.51 (d, J(C,P)=6.3 Hz, CH,
PPh3), 128.47 (d, J(C,P)=11.1 Hz, CH), 46.5 (CH2), 46.2 (CH3), 45.93
(CH2), 45.90 (CH3), 19.5 (CH2), 18.1 (CH2); 31P NMR (162 MHz,
CD2Cl2); d=26.5 (neutral), 22.2 (cationic), ꢀ4.6 (PPh3); IR (KBr): n˜ =
3049, 2916, 2850, 1697, 1629, 1575, 1522, 1629, 1575, 1522, 1493, 1480,
1434, 1402, 1359, 1318, 1240, 1217, 1185, 1159, 1094, 1025, 998, 856, 748,
695, 619, 599, 521, 495 cmꢀ1; MS (ESI-pos., CH2Cl2): m/z: 777.2 (cationic
complex, [M +ꢀCl]); elemental analysis calcd (%) for the cationic com-
plex: C 61.97, H 5.20, N 3.44; found C 62.10, H 5.12, N 3.38.
CH), 126.9 (CH), 112.7 (CH), 69.6 (CH3), 55.8 (CH), 55.5 (CH), 20.8
(CH3), 20.6 (CH3); 31P NMR (162 MHz, CD2Cl2): d=26.1; IR (KBr): n˜ =
3053, 2973, 2934, 2875, 2836, 1601, 1563, 1502, 1481, 1454, 1435, 1390,
1373, 1308, 1291, 1253, 1220, 1177, 1163, 1142, 1096, 1072, 1026, 1000,
838, 782, 747, 730, 693, 629, 595, 530, 510, 496, 456 cmꢀ1; MS (ESI-pos.):
m/z: 624.1 [M +ꢀCl], 586.1 [M +ꢀ2 Cl], 218.2 [M +ꢀ2ClꢀPPh3ꢀPd]; ele-
mental analysis calcd (%) for: C 58.33, H 5.51, N 2.13; found: C 58.24, H
5.59, N 2.16.
Compound 34: pale yellow solid (116 mg, 50%); 1H NMR (400 MHz,
CD2Cl2): d=7.50–7.26 (m, 15H), 6.71–6.70 (m, 4H), 5.52–5.45 (m, 1H),
4.06–3.99 (m, 1H), 3.81 (s, 3H), 3.10–3.04 (m, 1H), 2.54–2.48 (m, 1H),
1.92–1.85 (m, 2H), 1.68–1.50 (m, 4H); 13C NMR (100 MHz, CD2Cl2): d=
226.4 (d, J(C,P)=6.6 Hz, C), 161.1 (C), 134.6 (d, J(C,P)=11.4 Hz, CH),
133.7 (d, J=19.7 Hz, C), 131.1 (d, J(C,P)=2.7 Hz, CH), 130.5 (d,
J(C,P)=52.5 Hz, C), 129.0 (CH), 128.4 (d, J(C,P)=10.9 Hz, CH), 113.4
(CH), 63.7 (CH2), 55.6 (CH3), 55.1 (CH2), 26.6 (CH2), 25.7 (CH2), 23.7
(CH2); 31P NMR (162 MHz, CD2Cl2): d=26.0; IR (KBr): n˜ =3053, 2942,
2861, 2677, 1600, 1570, 1505, 1481, 1435, 1352, 1300, 1278, 1256, 1234,
1176, 1136, 1096, 1072, 1026, 999, 951, 858, 836, 804, 777, 746, 694, 606,
568, 532, 511, 498 cmꢀ1; MS (ESI-pos.): m/z: 868.2 [M +ꢀCl], 608.1 [M +
ꢀClꢀPPh3]; elemental analysis calcd (%) for: C 57.92, H 5.02, N 2.18;
found: C 57.84, H 5.10, N 2.21.
Compound 22: colorless solid (124 mg, 40%). In solution, this product
exists as an equilibrium mixture of the cationic form, the neutral form,
and PPh3 (neutral/cationic/PPh3 0.64:1:0.86). 1H NMR (400 MHz,
CD2Cl2): d=7.73–7.66 (m, 15H), 7.59–7.47 (m, 24H), 7.46–7.40 (m, 6H),
7.32–7.27 (m, 15H), 3.45 (s, 6H), 3.00 (s, 6H), 2.73 (s, 6H), 2.12 (s, 6H);
13C NMR (100 MHz, CD2Cl2): d=201.3 (C), 201.2 (C), 137.5 (d, J(C,P)=
20.1 Hz, C, PPh3), 134.6 (d, J(C,P)=11.1 Hz, CH), 134.4 (t, J(C,P)=
6.3 Hz, CH), 133.7 (d, J(C,P)=19.6 Hz, CH, PPh3), 131.9 (s, CH), 131.3
(d, J(C,P)=2.2 Hz, CH), 130.9 (d, J(C,P)=51.3 Hz, C), 129.6 (d, J(C,P)=
25.6 Hz, C), 129.3 (t, J(C,P)=5.3 Hz, CH), 128.8 (CH, PPh3), 128.6 (d,
J(C,P)=11.2 Hz, CH), 128.5 (CH, PPh3), 47.1 (CH3), 43.3 (CH3);
31P NMR (162 MHz, CD2Cl2): d=27.5 (neutral), 22.8 (cationic), ꢀ4.6
(PPh3); IR (KBr): n=3050, 2955, 2916, 2849, 2674, 1617, 1563, 1480,
1434, 1404, 1382, 1309, 1265, 1185, 1158, 1094, 1052, 1026, 997, 917, 868,
747, 694, 612, 521, 495 cmꢀ1; MS (ESI-pos.): m/z: 505.0 (neutral complex,
[M +ꢀCl]), 767.2 (cationic complex, [M +ꢀCl]; elemental analysis calcd
(%) for the neutral complex: C 51.18, H 5.04, N 5.19; found: C 51.08, H
5.11, N 5.08.
Compound 27a (X=O): clorless solid (190 mg, 35%); 1H NMR
(400 MHz, CD2Cl2): d = 7.50–7.46 (m, 3H), 7.40–7.20 (m, 17H), 3.80 (s,
3H), 3.01 (s, 3H); 13C NMR (75 MHz, CD2Cl2): d=204.8 (d, J=6.2 Hz,
C), 154.1 (C), 134.3 (d, J(C,P)=11.2 Hz, CH), 131.4 (d, J(C,P)=2.7 Hz,
CH), 129.6 (CH), 128.5 (d, J(C,P)=11.2 Hz, CH), 126.9 (C), 122.2 (CH),
115.7 (CH), 44.7 (CH3), 38.7 (CH3); 31P NMR (162 MHz, CD2Cl2): d=
26.17; IR (KBr): n˜ =3052, 2984, 2923, 1622, 1599, 1577, 1483, 1455, 1435,
1412, 1355, 1310, 1275, 1246, 1187, 1147, 1096, 1071, 1026, 999, 820, 759,
693, 609, 534, 510, 498 cmꢀ1; MS (ESI-pos.): m/z: 552.1 [M +ꢀCl]; ele-
mental analysis calcd (%) for: C 55.08, H 4.45, N 2.38, found: C 54.95, H
4.49, N 2.43.
Representative procedure for the formation of nickel complexes by oxi-
dative addition—Compound 37: [Ni(cod)2] (99 mg, 0.36 mmol) was added
to a solution of PPh3 (189 mg, 0.72 mmol) in anhydrous THF (10 mL)
and the dark red mixture was stirred for 15 min under argon. The imida-
zolium salt 1a (100 mg, 0.36 mmol) was then introduced and the resulting
brown-yellow suspension was stirred for 3 h at ambient temperature caus-
ing the precipitation of a yellow solid. This precipitate was allowed to
settle, the supernatant solution was siphoned off, and the solid was dried
in vacuo to give product 37 as a yellow solid (267 mg, 86%). Crystals
suitable for X-ray structure analysis were formed by slowly diffusing pen-
tane into
a
CH2Cl2 solution of the complex. 1H NMR (400 MHz,
CD2Cl2): d=7.75–7.71 (m, 12H), 7.61–7.50 (m, 18H), 3.13 (s, 6H), 2.49
(s, 4H); 13C NMR (100 MHz, CD2Cl2): d=197.1 (C), 134.3 (t, J(C,P)=
5.6 Hz, CH), 131.9 (CH), 129.1 (d, J(C,P)=48.2 Hz, C), 129.0 (d,
J(C,P)=5.5 Hz, CH), 51.0 (CH2), 36.8 (CH3); 31P NMR (121 MHz,
CD2Cl2): d=21.6, ꢀ143.9 (hept., J(P,F)=710.6 Hz); IR (KBr): n˜ =3057,
2957, 2924, 2884, 1646, 1587, 1572, 1543, 1516, 1482, 1435, 1402, 1323,
1287, 1208, 1190, 1095, 1028, 999, 838, 745, 695, 620, 558, 524, 513,
494 cmꢀ1; MS (ESI-pos.): m/z: 453.0 [M +ꢀPF6ꢀPPh3]; elemental analysis
calcd (%) for: 57.14, H 4.68, N 3.25; found: C 56.98, H 4.78, N 3.21.
The following complexes were analogously prepared:
Complex 38: yellow solid (223 mg, 62%); 1H NMR (400 MHz, CD2Cl2):
d=7.73–7.72 (m, 12H), 7.59–7.52 (m, 18H), 3.13 (s, 6H), 2.50 (s, 4H);
13C NMR (100 MHz, CD2Cl2): d=197.0 (C), 134.3 (t, J(C,P)=5.1 Hz,
CH), 131.9 (CH), 129.1 (d, J(C,P)=48.3 Hz, C), 129.0 (J(C,P)=5.1 Hz,
CH), 51.0 (CH2), 36.8 (CH3); 31P NMR (162 MHz, CD2Cl2): d=21.8; IR
(KBr): n˜ =3053, 2951, 2869, 2678, 1670, 1585, 1571, 1543, 1517, 1481,
1436, 1400, 1323, 1287, 1207, 1184, 1163, 1092, 1055, 998, 901, 805, 751,
698, 621, 522, 494 cmꢀ1; MS (ESI-pos.): m/z: 715.2 [M +ꢀBF4], 453.1 [M +
ꢀBF4ꢀPPh3]; elemental analysis calcd (%) for: C 61.27, H 5.02, N 3.49;
found: C 61.20, H 5.12, N 3.41.
Complex 39: yellow solid (160 mg, 77%); 1H NMR (400 MHz, CD2Cl2):
d=3.66 (t, J=1.3 Hz, 4H), 3.52 (s, 6H), 1.70–1.62 (m, 12H), 1.21 (quint.,
J=7.9 Hz, 18H); 13C NMR (100 MHz, CD2Cl2): d=198.3 (J(C,P)=
31.3 Hz, C), 51.6 (CH2), 37.4 (CH3), 15.0 (J(C,P)=13.9 Hz, CH3), 8.4
(CH2); 31P NMR (121 MHz, CD2Cl2): d=17.4, ꢀ143.9 (hept., J(P,F)=
710.6 Hz); IR (KBr): n=2971, 2942, 2882, 2801, 1537, 1517, 1483, 1458,
1435, 1407, 1380, 1325, 1292, 1260, 1210, 1101, 1038, 1014, 929, 876, 839,
756, 739, 725, 701, 631, 557 cmꢀ1; MS (ESI-pos.): m/z: 427.2 [M+-PF6],
309.1 [M+-PF6-PEt3]; elemental analysis calcd (%) for: C 35.60, H 7.03,
N 4.88; found: C 35.84, H 6.89, N 4.81.
Compound 27b (X=S): colorless solid (166 mg, 64%); 1H NMR
(400 MHz, CD2Cl2): d=7.95–7.93 (m, 2H), 7.65–7.60 (m, 3H), 7.49–7.43
(m, 7H), 7.35–7.27 (m, 19H), 3.94 (s, 3H), 3.05 (s, 3H); 13C NMR
(75 MHz, CD2Cl2): d=228.7 (C), 136.0 (CH), 134.5 (C), 132.1 (CH),
131.3 (d, J(C,P)=2.6 Hz, CH), 130.8 (CH), 129.7 (CH), 129.2 (CH), 128.4
(d, J(C,P)=11.1 Hz, CH), 44.7 (CH3); 31P NMR (162 MHz, CD2Cl2): d=
25.9; IR (KBr): n˜ =3142, 3052, 2962, 2919, 2854, 2673, 1667, 1585, 1572,
1545, 1480, 1435, 1403, 1310, 1263, 1228, 1186, 1157, 1117, 1094, 1070,
1026, 998, 923, 900, 857, 803, 746, 721, 693, 617, 557, 533, 512, 495 cmꢀ1
;
MS (ESI-pos.): m/z: 832.1 [M +ꢀCl], 570.0 [M +ꢀClꢀPPh3]; elemental
analysis calcd (%) for: C 62.33, H 4.77, N 1.62; found: C 62.26, H 4.83, N
1.65.
Complex 32: yellow solid (124 mg, 56%); 1H NMR (400 MHz, CD2Cl2):
d=7.50–7.34 (m, 15H), 6.67–6.58 (m, 4H), 6.16 (hept., J=6.6 Hz, 1H),
4.07 (hept., J=7.0 Hz, 1H), 3.81 (s, 3H), 1.86 (d, J=6.6 Hz, 3H), 1.44 (d,
J=6.8 Hz, 3H), 1.05 (d, J=7.0 Hz, 3H), 0.90 (d, J=7.0 Hz, 3H);
13C NMR (75 MHz, CD2Cl2): d=232.4 (d, J=8.2 Hz, C), 160.4 (C), 134.8
(d, J(C,P)=11.2 Hz, CH), 133.9 (d, J=2.9 Hz, C), 131.04 (d, J(C,P)=
52.5 Hz, C), 131.03 (d, J(C,P)=2.5 Hz, CH), 128.4 (d, J(C,P)=10.9 Hz,
Compound 40: yellow solid (193 mg, 41%); 1H NMR (400 MHz,
CD2Cl2): d=7.68–7.32 (m, 30H), 4.82 (m, 3H), 3.57 (m, 2H), 2.10 (m,
3H), 1.53–1.16 (m, 12H); 13C NMR (75 MHz, CD2Cl2): d=196.2 (C),
134.4 (CH), 131.7 (CH), 129.1 (t, J(C,P)=4.8 Hz, CH), 128.6 (C), 57.0
(CH2), 25.2 (CH2), 23.3 (CH2); 31P NMR (121 MHz, CD2Cl2): d=21.8,
1848
ꢃ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2005, 11, 1833 – 1853